Skip to search formSkip to main contentSkip to account menu

alaproclate

Known as: DL-Alanine, 2-(4-chlorophenyl)-1,1-dimethylethyl ester 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (3)

AlanineAntidepressive AgentsSerotonin Uptake Inhibitors

Narrower (2)

alaproclate hydrochloridealaproclate hydrochloride, (D)-isomer
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Attenuation of the post-decapitation convulsions after repeated treatment of rats with desipramine, imipramine and maprotiline.
The effects of repeated treatment of rats with the antidepressant or potential antidepressant agents alaproclate, citalopram… 
2004
2004
The effects of alaproclate on the pupillary responses to tyramine, phenylephrine and pilocarpine in depressed patients
Nine depressed patients were treated with alaproclate, a selective 5-HT uptake inhibitor, for 3 weeks in a dose of 400 mg daily… 
1985
1985
Effects of 5-hydroxytryptamine uptake blockers on the concentration in brain of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in male rats, pro-oestrous rats and ovariectomized rats treated with…
The aim of this study was to determine the effect of 5-hydroxytryptamine (5-HT) uptake blockade on 5-HT turnover by measuring the… 
1983
1983
Alaproclate: further pharmacological evidence for 5-HT uptake inhibition in vivo.
Alaproclate (2-/4-chlorophenyl/-1,1-dimethyl-2-amino-propanoate hydrochloride), a new selective 5-HT uptake inhibitor has been… 
Highly Cited
1978
Highly Cited
1978
Inhibitors of neuronal monoamine uptake. 2. Selective inhibition of 5-hydroxytryptamine uptake by alpha-amino acid esters of phenethyl alcohols.
A series of alpha-amino acid esters of substituted phenethyl alcohols was prepared and tested as inhibitors of the neuronal…